News

BioCryst posted a profitable third quarter on the back of Orladeyo, raised full‑year guidance, completed the sale of its...

BioNTech raised its 2025 revenue guidance to €2.6–2.8 billion and tightened spending plans after reporting third-quarter revenues of €1.52...

Nanobiotix has secured up to $71 million in non-dilutive financing from Healthcare Royalty, anchored to future economics from its...

DXS International posted audited results for the year ended 30 April 2025, reporting a 5% revenue rise to £3.47...

Nxera Pharma has unveiled a proprietary pipeline centered on obesity and chronic weight management, led by a differentiated oral...

Plus Therapeutics introduced its CNSide cerebrospinal fluid diagnostics platform into the U.S. market, secured a first national coverage agreement...

Ardelyx posted third-quarter 2025 revenue of $110.3 million, anchored by a sharp acceleration in IBSRELA, which delivered $78.2 million,...

TME Pharma has published its half-year results and outlined a restructuring that shifts the micro-cap biotech to an outsourced,...

Nurix Therapeutics will step onto the investor stage in November, with its president and CEO slated for fireside chats...

Amneal Pharmaceuticals posted third-quarter 2025 revenue of $785 million, up 12% year over year, and nudged its full-year outlook...